Terms ending in 2037
Every in-force patent on NeuroPace, Inc.'s record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,231,621 | Use of a Progressive Compression Encoding of Physiologic Waveform Data in an Implantable Device to Support Discontinuing Transmission of Low-Value Data In force · High confidence | Neuropace, Inc. | In force | High confidence | |
| US 10,219,229 | Transmit Power Level Determination for Communication Between an External Transceiver and an Implantable Transceiver In force · High confidence | Neuropace, Inc. | In force | High confidence | |
| US 10,506,531 | Transmit Power Level Determination for Communication Between an External Transceiver and an Implantable Transceiver In force · High confidence | Neuropace, Inc. | In force | High confidence | |
| US 10,729,352 | Neurological Event Detection Tools for Implantable Medical Devices In force · High confidence | Neuropace, Inc. | In force | High confidence |
4 of 4 patents shown. Soonest term end first, then patent number.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.